Selected publications
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
2016
Review
GET IT
Times cited: 2 -
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
2016
Academic Article
GET IT
Times cited: 19 -
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
2015
Review
GET IT
Times cited: 89 -
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Breast Cancer Research.
2014
Academic Article
GET IT
Times cited: 21